ADCIRCA

Brand name authorized in: Austria Australia Canada Germany Spain France Ireland Italy Lithuania Netherlands Poland United Kingdom United States

Active ingredients

The drug ADCIRCA contains one active pharmaceutical ingredient (API):

1 Tadalafil
UNII 742SXX0ICT - TADALAFIL

Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes the local release of nitric oxide, inhibition of PDE5 by tadalafil produces increased levels of cGMP in the corpus cavernosum. This results in smooth muscle relaxation and inflow of blood into the penile tissues, thereby producing an erection. Tadalafil has no effect in the absence of sexual stimulation.

Read about Tadalafil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Tadalafil
G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE08

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 12150L, 12151M, 1304P, 1308W
CA
Health Products and Food Branch
Identifier(s): 02338327
DE
Bundesinstitut für Arzneimittel und Medizinprodukte
Identifier(s): 05908891, 05908916, 10536687
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 08476006
FR
Base de données publique des médicaments
Identifier(s): 63206355
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 182492
IE
Health Products Regulatory Authority
Identifier(s): 88530
IT
Agenzia Italiana del Farmaco
Identifier(s): 39598026
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1056532, 1056533
NL
Z-Index G-Standaard, PRK
Identifier(s): 68241
PL
Rejestru Produktów Leczniczych
Identifier(s): 100206193
US
FDA, National Drug Code
Identifier(s): 43353-070, 66302-467